Callitas Health Inc. Stock Deutsche Boerse AG
Equities
T3F3
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 0.7 1.03 | Sales 2019 | 0.71 0.67 0.98 | Capitalization | 3.53M 3.31M 4.86M |
---|---|---|---|---|---|
Net income 2018 | -5M -4.69M -6.89M | Net income 2019 | -1M -938K -1.38M | EV / Sales 2018 | 4,852,616 x |
Net Debt 2018 | 319K 299K 439K | Net Debt 2019 | 848K 795K 1.17M | EV / Sales 2019 | 6,168,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-01-02 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 14-11-30 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |